beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid - PubMed (original) (raw)

beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid

T Farmer et al. Antimicrob Agents Chemother. 1982 Mar.

Abstract

Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.

PubMed Disclaimer

Similar articles

• Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
  Stobberingh EE, Davies BI, van Boven CP. Stobberingh EE, et al. J Antimicrob Chemother. 1984 Jan;13(1):55-64. doi: 10.1093/jac/13.1.55. J Antimicrob Chemother. 1984. PMID: 6607919
• Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
  Philippon A, Riou JY, Guibourdenche M, Sotolongo F. Philippon A, et al. Drugs. 1986;31 Suppl 3:64-9. doi: 10.2165/00003495-198600313-00014. Drugs. 1986. PMID: 3015547
• Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
  Bedenić B, Zagar Z. Bedenić B, et al. J Chemother. 1994 Dec;6(6):383-7. doi: 10.1080/1120009x.1994.11736493. J Chemother. 1994. PMID: 7699424
• [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].
  Chaïbi EB, Mugnier P, Kitzis MD, Goldstein FW, Acar JF. Chaïbi EB, et al. Res Microbiol. 1995 Nov-Dec;146(9):761-71. doi: 10.1016/0923-2508(96)81072-2. Res Microbiol. 1995. PMID: 8584798 Review. French.
• Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
  Neu HC. Neu HC. Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8. Am J Med. 1985. PMID: 3907341 Review.

Cited by

• Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
  Zhanel GG, Palatnick L, Nichol KA, Low DE, Hoban DJ; CROSS Study Group. Zhanel GG, et al. Antimicrob Agents Chemother. 2003 Jun;47(6):1875-81. doi: 10.1128/AAC.47.6.1875-1881.2003. Antimicrob Agents Chemother. 2003. PMID: 12760861 Free PMC article.
• Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
  Richter SS, Winokur PL, Brueggemann AB, Huynh HK, Rhomberg PR, Wingert EM, Doern GV. Richter SS, et al. Antimicrob Agents Chemother. 2000 Feb;44(2):444-6. doi: 10.1128/AAC.44.2.444-446.2000. Antimicrob Agents Chemother. 2000. PMID: 10639381 Free PMC article.
• Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
  McGregor K, Chang BJ, Mee BJ, Riley TV. McGregor K, et al. Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9707304 Review.
• [Moraxella catarrhalis: virulence and resistance mechanisms].
  Cullmann W. Cullmann W. Med Klin (Munich). 1997 Mar 15;92(3):162-6. doi: 10.1007/BF03043274. Med Klin (Munich). 1997. PMID: 9173208 Review. German.

References

1. 1. Biochem J. 1972 Mar;127(1):295-308 - PubMed
2. 1. Antimicrob Agents Chemother. 1972 Apr;1(4):283-8 - PubMed
3. 1. Am Rev Respir Dis. 1976 Aug;114(2):399-402 - PubMed
4. 1. Lancet. 1977 Jul 16;2(8029):149 - PubMed
5. 1. Antimicrob Agents Chemother. 1977 May;11(5):852-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations